Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 May 9;13(5):399.
doi: 10.3390/pathogens13050399.

Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested against Bovine Isolates of Mannheimia haemolytica and Pasteurella multocida

Joseph M Blondeau  1   2 , Shantelle D Fitch  1
Affiliations
Comparative Study

Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested against Bovine Isolates of Mannheimia haemolytica and Pasteurella multocida

Joseph M Blondeau et al. Pathogens. .

Abstract

Pradofloxacin-a dual-targeting fluoroquinolone-is the most recent approved for use in food animals. Minimum inhibitory and mutant prevention concentration values were determined for pradofloxacin, ceftiofur, enrofloxacin, florfenicol, marbofloxacin, tildipirosin, tilmicosin, and tulathromycin. For M. haemolytica strains, MIC50/90/100 values were ≤0.016/≤0.016/≤0.016 and MPC50/90/100 values were 0.031/0.063/0.063; for P. multocida strains, the MIC50/90/100 values ≤0.016/≤0.016/0.031 and MPC50/90/100 ≤ 0.016/0.031/0.063 for pradofloxacin. The pradofloxacin Cmax/MIC90 and Cmax/MPC90 values for M. haemolytica and P. multocida strains, respectively, were 212.5 and 53.9 and 212.5 and 109.7. Similarly, AUC24/MIC90 and AUC24/MPC90 for M. haemolytica were 825 and 209.5, and for P. multocida, they were 825 and 425.8. Pradofloxacin would exceed the mutant selection window for >12-16 h. Pradofloxacin appears to have a low likelihood for resistance selection against key bovine respiratory disease bacterial pathogens based on low MIC and MPC values.

Keywords: MIC/MPC; Mannheimia haemolytica; Pasteurella multocida; pradofloxacin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Gaudino M., Nagamine B., Ducatez M.F., Meyer G. Understanding the mechanisms of viral and bacterial coinfections in bovine respiratory disease: A comprehensive literature review of experimental evidence. Vet. Res. 2022;53:70. doi: 10.1186/s13567-022-01086-1. - DOI - PMC - PubMed
    1. Callan R.J., Garry F.B. Biosecurity and bovine respiratory disease. Vet. Clin. N. Am. Food Anim. Pract. 2002;18:57–77. doi: 10.1016/s0749-0720(02)00004-x. - DOI - PMC - PubMed
    1. Blakebrough-Hall C., McMeniman J.P., González L.A. An evaluation of the economic effects of bovine respiratory disease on animal performance, carcass traits, and economic outcomes in feedlot cattle defined using four BRD diagnosis methods. J. Anim. Sci. 2020;98:skaa005. doi: 10.1093/jas/skaa005. - DOI - PMC - PubMed
    1. Loneragan G.H., Dargatz D.A., Morley P.S., Smith M.A. Trends in mortality ratios among cattle in US feedlots. J. Am. Vet. Med. Assoc. 2001;219:1122–1127. doi: 10.2460/javma.2001.219.1122. - DOI - PubMed
    1. Preview: Economic Effects of Bovine Respiratory Disease. J. Anim. Sci. 2020;98:skaa042. doi: 10.1093/jas/skaa042. - DOI - PMC - PubMed

Publication types

MeSH terms